Title: Debrisoquin
CAS Registry Number: 1131-64-2
CAS Name: 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide
Additional Names: 3,4-dihydro-2(1H)-isoquinolinecarboxamidine; 2-amidino-1,2,3,4-tetrahydroisoquinoline; isocaramidine
Molecular Formula: C10H13N3
Molecular Weight: 175.23
Percent Composition: C 68.54%, H 7.48%, N 23.98%
Literature References: Prepn of derivs: W. Wenner, BE 629007; idem, US 3157573 (1963, 1964 both to Hoffmann-La Roche); idem, J. Med. Chem. 8, 125 (1965). Pharmacology: Moe et al., Curr. Ther. Res. 6, 299 (1964); Abrams et al., J. New Drugs 4, 268 (1964). Possible mechanism of action: Medina et al., Biochem. Pharmacol. 18, 891 (1969); Pocelinko et al., Int. Z. Klin. Pharmakol. Ther. Toxikol. 2, 13 (1969). Toxicity study: E. I. Goldenthal, Toxicol. Appl. Pharmacol. 18, 185 (1971).
Derivative Type: Sulfate
CAS Registry Number: 581-88-4
Manufacturers' Codes: Ro-5-3307/1
Trademarks: Declinax (Roche); Tendor (Chinoin)
Molecular Formula: 2(C10H13N3).H2SO4
Molecular Weight: 448.54
Percent Composition: C 53.55%, H 6.29%, N 18.74%, S 7.15%, O 14.27%
Properties: Crystals, mp 278-280°, 284-285° or 266-268° (H2O), depending on humidity. Freely sol in water. LD50 in neonate, adult rats (mg/kg): 88 ±18, 1580 ±163 orally (Goldenthal).
Melting point: mp 278-280°, 284-285° or 266-268° (H2O)
Toxicity data: LD50 in neonate, adult rats (mg/kg): 88 ±18, 1580 ±163 orally (Goldenthal)
Therap-Cat: Antihypertensive.
Keywords: Antihypertensive; Guanidine Derivatives.
Decaborane(14) Decalin? Decamethonium Bromide Decamethylcyclopentasiloxane Decamethylene Glycol

CAS number 1131-64-2 YesY
PubChem 2966
ChemSpider 2860 YesY
DrugBank DB04840
KEGG C13650 YesY
MeSH Debrisoquine
ChEBI CHEBI:34665 YesY
ATC code C02CC04
Jmol-3D images Image 1
Molecular formula C10H13N3
Molar mass 175.23032
 YesY (verify) (what is: YesY/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug metabolizing enzyme.[2]